Reckitt Benckiser Group
RBGLY | OTC
$13.49
+$0.05 (+0.37%)
Sep 22, 2026, 1:35 PM ET · Market open
+0.37%
(1D)Rating
Updated: Sep 17, 2026Key Statistics
Market Data
Market Cap $42.84B
1D Range
13.42 13.63
52W Range
12.02 17.80
Valuation (TTM)
PE 28.02
PB 4.92
EV/EBITDA 14.19
Valuation (NTM)
Forward PE 13.58
Forward PEG 1.56
Price Target N/A
Cash Flow
FCF Yield 6.3%
SBC Adj. FCF Yield 6.0%
SBC Impact -4.8%
Margins
Gross Margin 59.5%
Operating Margin 16.1%
FCF Margin 14.4%
Growth (CAGR)
Revenue 3Y | 5Y 3.3% |
9.5%
Dil EPS 3Y | 5Y -2.6% |
-4.7%
FCF 3Y | 5Y 1.1% |
1.0%
Returns
ROA 11.8%
ROE 42.9%
ROIC 16.9%
Financial Health
Net Debt
£8.06B ($11.06B)
Current Ratio 0.59
Interest Coverage 8.75
Dividends
Div Yield 10.79%
Payout Ratio 391.8%
FCF Payout Ratio 69.0%
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
6 days ago · wsj.com
Lysol and Mucinex Maker Reckitt Expands U.S. ManufacturingPlus, the U.S. is pressuring Mexico over AI-hardware exports, and consumers have paid an extra $107 billion for fuel since the Iran war started.
6 days ago · defenseworld.net
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Average Recommendation of “Moderate Buy” by AnalystsShares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have earned a consensus rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and two have given a strong buy
Add to Watchlist
Select watchlists to add or remove RBGLY